Dealmaking

'Insurance is cycle-agnostic at some level,' says Carlyle's James Burr on $1.78bn NSM deal

'It's a very fragmented market in both the US and the UK to the extent that if you have the proper platform and management team, there are a lot of M&A opportunities,' Burr says.

Spotlight on Vance Street’s healthcare strategy; surge in UK PE deals for European corporates

PE Hub casts a spotlight on Vance Street Capital.

Climate investing: Why it really is different this time

Three key climate tech sectors had more than 100 exits in 2021, compared to just a quarter of that number five years ago, signaling that investors are already generating ROI.

Vance Street brings sector expertise to medtech companies like Wytech

'We have an incredible network, because we have been investing in medtech and life science companies for more than 20 years,' said Vance Street's Brian Martin.

PE-backed telecom deals are on the rise, with Centre, Crestview, CDPQ and Grain among recent buyers

Deal drivers include increased demand for podcasts, video games, mobile apps, cloud computing, online gambling, artificial intelligence, and augmented and virtual reality software.

Private Equity Jobs of the Week: Neuberger Berman, HarbourView and Grosvenor are hiring

This week’s jobs include a marketing manager at Grosvenor, an associate spot at Neuberger Berman and an analyst at HarbourView.

Thoma Bravo and the plan for Vivian Health; TA invests in talent acquisition platform

TA backs iCIMS.

Thoma Bravo has ambitious plans for Vivian Health, including an IPO one day

Vivian Health provides an employment marketplace, like LinkedIn for healthcare, explained Thoma Bravo’s Christine Kang.

ACP finds it’s a good time to for exits; 40 under 40 features Adenia’s Martha Osier

PEI recognizes 40 under 40.

Inside the exits: ACP sold five portfolio companies in the last year

"We believe the exit environment has remained healthy with robust appetite for high-quality companies of scale," said Align Capital Partners' Chris Jones.